Ettore Pelosi M.D.
Curriculum Vitae
e.pelosi@irmet.com
ettore.pelosi@gmail.com
Birth date: July-12 1972; Lucca Italy
Resident in Turin, Italy
Mobile Phone 0039 320 5585931
Status Married (with four children)
Clean Driving License
Education
University “Politecnica delle Marche” Sept 2009 – Apr 2010
nd
International Master of 2 level: “Nutrizione e Dietetica” 110/110 cum laude
European Fellowship in Nuclear Medicine Oct 2008:
University of Turin Dec 2001 – Dev 2004
Faculty of Medicine
PhD: Radioimmunolocalization of human tumour
University of Turin Dec 1997 – Nov 2001
Faculty of Medicine
Specialization in Nuclear Medicine 70/70 cum Laude
University of Pisa Sept 1990 – Sept 1996
Faculty of Medicine
Degree 110/110 cum Laude
Employment
Nuclear Medicine Physician February 2004 – present
IRMET (Euromedic) – Turin Italy
PET Centre
Nuclear Medicine Physician April 2003 – January 2006
Molinette Hospital – Turin Italy
University Dept of Nuclear Medicine
Nuclear Medicine Physician April 2002 – March 2004
S. Raffaele Hospital – Milan Italy
University Dept of Nuclear Medicine
Honors and Awards
- Certificate in Advanced English – RN 01CITO175004, University of Cambridge; Dec 2001.
- French Language spoken and written.
- Winner of the 14th Doniselli prize, 2004: New technology in breast cancer treatment.
Scinetific Affiliations
Ordinary member of the Italian Society of Nuclear Medicine (AIMN; since 1998)
Ordinary member of the European Society of Nuclear Medicine (EANM; since 2002)
Ordinary member of the European Society of Nuclear Medicine (SNM; since 2007)
Ordinary member of the European Society of Nuclear Medicine (RSNA; since 2007)
Hobbies and Sports
Marathon Running (personal record 2h 41’ 07”)
References
Gianni Bisi MD
gianni.bisi@unito.it
Ferruccio Fazio MD
fazio.ferruccio@hsr.it
Giorgio Vittorio Scagliotti MD
scagliotti@ihnet.it
Scientific Pubblication
1. Pelosi E, Skanjeti A, Penna D, Arena V. Role of integrated PET/CT with [(18)F]-FDG
in the management of patients with fever of unknown origin: a single-centre
experience. Radiol Med. 2011 Mar 7. [Epub ahead of print]
2. Pelosi E, Penna D, Douroukas A, Bellò M, Amati A, Arena V, Passera R, Bisi G. Bone
marrow disease detection with FDG-PET/CT and bone marrow biopsy during the
staging of malignant lymphoma: results from a large multicentre study. Q J Nucl Med
Mol Imaging. 2010 Dec 9. [Epub ahead of print]
3. Pelosi E, Billè A, Skanjeti A, Errico L, Arena V, Ardissone F, Borasio P, Mancini M.
Prognostic role of the PET parameter maximum standardized uptake value in non
small cell lung cancer: analysis in tumour of diameter ≥ and <25 mm. Q J Nucl Med
Mol Imaging. 2011 Feb;55(1):72-80. Epub 2010 Jun 11.
4. Piccoli GB, Consiglio V, Arena V, Pelosi E, Anastasios D, Ragni F, Fiori C, Cortese G,
Deagostini MC, Porpiglia F, Scarpa RM. Positron emission tomography as a tool for
the 'tailored' management of retroperitoneal fibrosis: a nephro-urological experience.
Nephrol Dial Transplant. 2010 Aug;25(8):2603-10. Epub 2010 Feb 15 2010.
5. Pelosi E, Billè A, Skanjeti A, Arena V, Ardissone F. Accuracy of PET/CT with FDG in
mediastinal lymph node staging of patients with NSCLC. Health 2010;2(3):204-210
6. Pirro V, Skanjeti A, Pelosi E. PET in uterine malignancies. Health 2010;2(7):652-660
7. Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung
cancer: accuracy of integrated positron emission tomography and computed
tomography. Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. Epub 2009 May 22.
Review.
8. Douroukas A, Arena V, Pelosi E. Detection of metastatic involvement of the
pericardium on F-18 FDG-PET/CT imaging. Clin Nucl Med. 2009 Jan;34(1):40-1.
9. Mistrangelo M, Pelosi E, Bellò M, Castellano I, Cassoni P, Ricardi U, Munoz F, Racca
P, Contu V, Beltramo G, Morino M, Mussa A. Comparison of Positron Emission
Tomography Scanning and Sentinel Node Biopsy in the Detection of Inguinal Node
Metastases in Patients With Anal Cancer. Int J Radiat Oncol Biol Phys. 2010 May
1;77(1):73-8. Epub 2009 Jul 23.
10. Carbone R, Douroukas A, Arena V, Cantalupi D, Balleari E, Ghio R, Pelosi E. Does
18F-fluorodeoxyglucose PET/CT have a role in the management of pulmonary and
extra pulmonary sarcoidosis? Monaldi Arch Chest Dis. 2008 Jun;69(2):81-2.
11. Arena V, Skanjeti A, Casoni R, Douroukas A, Pelosi E. Dual-phase FDG-PET:
delayed acquisition improves hepatic detectability of pathological uptake. Radiol Med.
2008 Sep;113(6):875-86. Epub 2008 Jul 10.
12. Mistrangelo M, Bellò M, Mobiglia A, Beltramo G, Cassoni P, Milanesi E, Cornaglia S,
Pelosi E, Giunta F, Sandrucci S, Mussa A. Feasibility of the sentinel node biopsy in
anal cancer. Q J Nucl Med Mol Imaging. 2009;53(1):3-8. Epub 2008 Mar 12. [Epub
ahead of print].
13. Pelosi E, Arena V, Skanjeti A, Pirro V, Douroukas A, Pupi A, Mancini M. Role of whole
body 18F-Choline Positron Emission Tomography/Computer Tomography study in
disease detection in patients radically treated for prostate cancer with biochemical
relapse. Radiol Med. 2008 Sep;113(6):895-904. Epub 2008 Apr 14. [Epub ahead of
print].
14. Pelosi E, Pregno P, Penna D, Deandreis D, Chiappella A, Limerutti G, Vitolo U,
Mancini M, Gallo E, Bisi G. Role of whole body [18F]-fluorodeoxyglucose-positron
emission tomography / computed tomography (FDG-PET/CT) scan and conventional
techniques in the staging of patients with Hodgkin and aggressive Non Hodgkin
Lymphoma. Radiol Med. 2008 Jun;113(4):578-90. Epub 2008 Apr 14. [Epub ahead of
print].
15. Pelosi E, Skanjeti A, Cistaro A, Arena V. Fluorodeoxyglucose-positron emission
tomography/computed tomography in the staging and evaluation of treatment
response in a patient with Castleman's disease: a case report. J Med Case Reports.
2008;3(2):99.
16. Pelosi E, Penna D, Deandreis D, Chiappella A, Skanjeti A, Vitolo U, Bisi G. FDG-PET
in the detection of bone marrow disease in Hodgkin’s Disease and aggressive non-
Hodgkin’s lymphoma and its impact on clinical management. Q J Nucl Med Mol
Imaging. 2008;52(1):9-16.
17. Rigacci L, Vitolo U, Nassi L, Merli F, Gallamini A, PregnoP, Alvarez I, Salvi F, Sancetta
R, Castagnoli A, Versari A, Biggi A, Gregianin M, Pelosi E, Chisesi T, Bosi A, Levis A.
Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A
prospective multicentric study by the Intergruppo Italiano Linfomi. On behalf of
Intergruppo Italiano Linfomi. Ann. Hematol 2007;86(12):897-903.
18. Pelosi E, Deandreis D. The role of 18F-fluoro-deoxy-glucose positron emission
tomography (FDG-PET) in the management of patients with colorectal cancer. EJSO.
2007; 33(1):1-6. Review.
19. Pirro V, Skanjeti A, Pelosi E. 18F-Fluorodeoxyglucose-Positron Emission Tomography
in the Characterization of Suspected Rhabdoid Renal Tumor Recurrence: A Case
Report. J Pediatr Hematol Oncol. 2007;29:69-71.
20. Gallamini A, Rigacci L, Merli F, Nassi L, Bosi A, Capodanno I, Luminari S, Vitolo U,
Sancetta R, Iannitto E, Trentin L, Stelitano C, Tavera S, Biggi A, Castagnoli A, Versari
A, Gregianin M, Pelosi E, Torchio P, Levis A. The predictive value of positron
emission tomography scanning performed after two courses of standard therapy on
treatment outcome in advanced stage Hodgkin's disease. Haematologica. 2006;
91(4):475-81.
21. Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G. Role of whole
body positron emission tomography/computed tomography scan with 18F-
fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown
primary site. Q J Nucl Med Mol Imaging. 2006; 50(1):15-22.
22. Pelosi E, Ala A, Bellò M, Douroukas A, Migliaretti G, Berardengo E, Varetto T,
Bussone R, Bisi G. Impact of axillary nodal metastases on lymphatic mapping and
sentinel lymph node identification rate in patients with early stage breast cancer. Eur J
Nucl Med Mol Imaging, 2005; 32(8):937-942.]
23. Kim CK, Krynyckyi BR, Machac J, Pelosi E, Bisi G. Periareolar injections and hot
sentinel nodes. J Nucl Med, 2004; 45(9):1597-9; author reply 1599.
24. Messa C, Bettinardi V, Picchio M, Pelosi E, Landoni C, Gianolli L, Gilardi MC, Fazio F.
PET/CT in diagnostic oncology. Q J Nucl Med Mol Imaging. 2004; 48(2):66-75.
25. Pelosi E, Messa C, Sironi S, Picchio M, Landoni C, Bettinardi V, Gianolli L, Del
Maschio A, Gilardi MC, Fazio F. Value of integrated PET/CT for lesion localization in
cancer patients: a comparative study. Eur J Nucl Med Mol Imaging, 2004; 31(7):932-
939.
26. Pelosi E, Pellerito R, Clerico P, Migliaretti G, Rosso U, Bisi G. Characterisation of the
Ideal Candidate to Knee Radiosynoviorthesis Treatment in Patients with Rheumatoid
Arthritis. Nucl Med Comm, 2004; 25(6):603-608.
27. Pelosi E, Baiocco C, Pennone M, Migliaretti G, Varetto T, Maiello A, Bellò M, Bisi G.
99m
Tc-HMPAO-Leukocytes Scintigraphy in Patients with Symptomatic Total Hip or
Knee Arthroplasty: Improved Diagnostic Accuracy by Means of Semi-Quantitative
Evaluation. J Nucl Med, 2004; 45(3): 438-444.
28. Pelosi E, Bellò M, Giors M, Ala A, Giani R, Bussone R, Bisi G. Sentinel Lymph Node
Detection in Patients with Early Stage Breast Cancer: Comparison between
Periareolar and Subdermal/Peritumoral Injection Technique. J Nucl Med, 2004; 45(2):
220-225.
29. Ceresoli GL, Schipani S, Bencardino KB, Messa C, Pelosi E, Fazio F. Ruolo della
tomografia ad emissione di positroni (PET) in oncologia - parte prima. TECHNE, 2003;
7(3): 160-170.
30. Ceresoli GL, Bencardino KB, Schipani S, Pelosi E, Messa C, Fazio F. Ruolo della
tomografia ad emissione di positroni (PET) in oncologia - parte seconda. TECHNE,
2003; 7(4): 215-226.
31. Pelosi E, Arena V, Baudino B, Bellò M, Giusti M, Tigelio G, Palladin D, Bisi G.
Preoperative Lymphatic Mapping and Intraoperative Sentinel Lymph Node Detection in
Early Stage Endometrial Cancer. Nucl Med Commun, 2003; 24,971-75.
32. Pelosi E, Baiocco C, Ala A, Gay E, Bellò M, Giani R, Bussone R, Varetto T, Bisi G.
Lymphatic Mapping in Early Stage Breast Cancer: Comparison between Periareolar
and Subdermal Injection. Nucl Med Commun, 2003; 24: 519-523.
33. Pelosi E, Picchio M, Landoni C, Gianolli L, Cistaro A, Messa C, Fazio F. The role of
positron emission tomography in the diagnosis of indeterminate solitary nodule.
Minerva Pneumologica, 2002, 41(2): 23-30.
34. Podio V, Spinnler MT, Bertuccio G, Carbonero C, Pelosi E, Bisi G. Prognosis of
hibernating myocardium is independent of recovery of function: evidence from a
routine based follow-up study. Nucl Med Commun, 2002; 23(10): 933-942.
35. Mistrangelo M, Mobiglia A, Mussa B, Bellò M, Pelosi E, Goss M, Bosso MC, Moro F,
Sandrucci S. The sentinel node in anal carcinoma. Tumori, 2002; 88(3): S51-52.
36. Pelosi E, Arena V, Bellò M, Cesana P, Lamberti L, Spandonari T, Ropolo R,
Sandrucci S, Bisi G. Radiolabeled localization of the sentinel lymph node: dosimetric
evaluation in personnel involved in the procedure. Tumori, 2002; 88(3): S7-8.
37. Pelosi E, Arena V, Baudino B, Bellò M, Gargiulo T, Giusti M, Bottero A, Leo L,
Armellino F, Palladin D, Bisi G. Preliminary study of sentinel node identification with
99mTc colloid and blue dye in patients with endometrial cancer. Tumori, 2002; 88(3):
S9-10.
38. Pelosi E, Arena V, Baudino B, Bellò M, Giani R, Lauro D, Ala A, Bussone R, Bisi G.
Sentinel node detection in breast carcinoma. Tumori, 2002; 88(3): S10-11.
39. Pelosi E, Masaneo I, Clara R, Valetto MR, Bellò M, Zanon C, Chiappino I, Grosso M,
Mussa A, Bisi G. Technetium-99m labelled macroaggregated albumin arterial catheter
perfusion scintigraphy: prediction of gastrointestinal toxicity in hepatic arterial
chemotherapy. Eur J Nucl Med. 2000; 27(6): 668-675.
40. Pelosi E, Bellò M, Zanon C, Grosso M, Clara R, Alabiso O, Bisi G, Mussa A.
Extrahepatic regional chemotherapy: use of technetium-99m labeled macroaggregated
albumin. Am J Clin Oncol. 1999; 22(3): 315-319.
41. Pelosi E, Bar F, Battista S, Bellò M, Bucchi MC, Alabiso O, Molino G, Bisi G. Hepatic
arterial infusion chemotherapy for unresectable confined liver metastases: prediction
of systemic toxicity with the application of a scintigraphic and pharmacokinetic
approach. Cancer Chemother Pharmacol. 1999; 44(6): 505-510.
42. Bisi G, Podio V, Valetto MR, Broglio F, Bertuccio G, Aimaretti G, Pelosi E, Del Rio G,
Muccioli G, Ong H, Boghen MF, Deghenghi R, Ghigo E. Cardiac effects of hexarelin in
hypopituitary adults. Eur J Pharmacol. 1999, 17;381(1): 31-38.